nodes	percent_of_prediction	percent_of_DWPC	metapath
Thiotepa—CYP3A4—type 2 diabetes mellitus	0.363	1	CbGaD
Thiotepa—CYP3A4—Linagliptin—type 2 diabetes mellitus	0.0588	0.152	CbGbCtD
Thiotepa—CYP3A4—Sitagliptin—type 2 diabetes mellitus	0.0524	0.136	CbGbCtD
Thiotepa—CYP3A4—Glipizide—type 2 diabetes mellitus	0.0479	0.124	CbGbCtD
Thiotepa—CYP3A4—Repaglinide—type 2 diabetes mellitus	0.0419	0.109	CbGbCtD
Thiotepa—CYP3A4—Pioglitazone—type 2 diabetes mellitus	0.0379	0.0982	CbGbCtD
Thiotepa—CYP3A4—Nateglinide—type 2 diabetes mellitus	0.0287	0.0744	CbGbCtD
Thiotepa—CYP3A4—Irbesartan—type 2 diabetes mellitus	0.0275	0.0713	CbGbCtD
Thiotepa—CYP3A4—Orlistat—type 2 diabetes mellitus	0.0275	0.0713	CbGbCtD
Thiotepa—CYP3A4—Bromocriptine—type 2 diabetes mellitus	0.026	0.0675	CbGbCtD
Thiotepa—CYP3A4—Glyburide—type 2 diabetes mellitus	0.0194	0.0503	CbGbCtD
Thiotepa—CYP3A4—Losartan—type 2 diabetes mellitus	0.0177	0.046	CbGbCtD
Thiotepa—CYP2B6—CYP2E1 reactions—CYP2E1—type 2 diabetes mellitus	0.000511	0.0303	CbGpPWpGaD
Thiotepa—CYP3A4—Codeine and Morphine Metabolism—ABCC2—type 2 diabetes mellitus	0.000441	0.0262	CbGpPWpGaD
Thiotepa—CYP2B6—Constitutive Androstane Receptor Pathway—NCOA6—type 2 diabetes mellitus	0.000399	0.0237	CbGpPWpGaD
Thiotepa—CYP3A4—Aflatoxin B1 metabolism—CYP1A2—type 2 diabetes mellitus	0.00033	0.0196	CbGpPWpGaD
Thiotepa—CYP2B6—Constitutive Androstane Receptor Pathway—ABCC2—type 2 diabetes mellitus	0.00032	0.019	CbGpPWpGaD
Thiotepa—CYP2B6—Xenobiotics—CYP2E1—type 2 diabetes mellitus	0.000317	0.0188	CbGpPWpGaD
Thiotepa—CYP2B6—Xenobiotics—CYP1A2—type 2 diabetes mellitus	0.000313	0.0186	CbGpPWpGaD
Thiotepa—CYP2B6—Xenobiotics—CYP3A4—type 2 diabetes mellitus	0.000306	0.0181	CbGpPWpGaD
Thiotepa—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCC2—type 2 diabetes mellitus	0.000305	0.0181	CbGpPWpGaD
Thiotepa—CYP3A4—Irinotecan Pathway—ABCC2—type 2 diabetes mellitus	0.000282	0.0167	CbGpPWpGaD
Thiotepa—CYP3A4—Liver X Receptor Pathway—SREBF1—type 2 diabetes mellitus	0.000274	0.0163	CbGpPWpGaD
Thiotepa—CYP3A4—Aflatoxin B1 metabolism—GSTM1—type 2 diabetes mellitus	0.000253	0.015	CbGpPWpGaD
Thiotepa—CYP3A4—Oxidation by Cytochrome P450—CYB5R4—type 2 diabetes mellitus	0.000245	0.0145	CbGpPWpGaD
Thiotepa—CYP3A4—Drug Induction of Bile Acid Pathway—ABCC2—type 2 diabetes mellitus	0.000241	0.0143	CbGpPWpGaD
Thiotepa—CYP3A4—Tryptophan metabolism—AANAT—type 2 diabetes mellitus	0.000218	0.013	CbGpPWpGaD
Thiotepa—CYP2B6—Constitutive Androstane Receptor Pathway—CYP3A4—type 2 diabetes mellitus	0.00021	0.0125	CbGpPWpGaD
Thiotepa—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2E1—type 2 diabetes mellitus	0.000207	0.0123	CbGpPWpGaD
Thiotepa—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP1A2—type 2 diabetes mellitus	0.000205	0.0122	CbGpPWpGaD
Thiotepa—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP3A4—type 2 diabetes mellitus	0.0002	0.0119	CbGpPWpGaD
Thiotepa—CYP3A4—Constitutive Androstane Receptor Pathway—NCOA6—type 2 diabetes mellitus	0.000181	0.0108	CbGpPWpGaD
Thiotepa—CYP2B6—Constitutive Androstane Receptor Pathway—PPARGC1A—type 2 diabetes mellitus	0.000178	0.0106	CbGpPWpGaD
Thiotepa—CYP3A4—Fatty Acid Omega Oxidation—CYP2E1—type 2 diabetes mellitus	0.000172	0.0102	CbGpPWpGaD
Thiotepa—CYP3A4—Fatty Acid Omega Oxidation—CYP1A2—type 2 diabetes mellitus	0.00017	0.0101	CbGpPWpGaD
Thiotepa—CYP2B6—Cytochrome P450 - arranged by substrate type—CYP11A1—type 2 diabetes mellitus	0.000159	0.00946	CbGpPWpGaD
Thiotepa—CYP2B6—Oxidation by Cytochrome P450—CYP11A1—type 2 diabetes mellitus	0.000157	0.00934	CbGpPWpGaD
Thiotepa—CYP3A4—Estrogen metabolism—CYP1A2—type 2 diabetes mellitus	0.000155	0.00919	CbGpPWpGaD
Thiotepa—Somnolence—Gliclazide—type 2 diabetes mellitus	0.000153	0.000652	CcSEcCtD
Thiotepa—Hypertension—Metformin—type 2 diabetes mellitus	0.000152	0.000649	CcSEcCtD
Thiotepa—Urticaria—Glyburide—type 2 diabetes mellitus	0.000152	0.000649	CcSEcCtD
Thiotepa—Nervousness—Losartan—type 2 diabetes mellitus	0.000152	0.000649	CcSEcCtD
Thiotepa—Skin disorder—Orlistat—type 2 diabetes mellitus	0.000151	0.000647	CcSEcCtD
Thiotepa—Connective tissue disorder—Ramipril—type 2 diabetes mellitus	0.000151	0.000646	CcSEcCtD
Thiotepa—Back pain—Losartan—type 2 diabetes mellitus	0.000151	0.000646	CcSEcCtD
Thiotepa—Abdominal pain—Glyburide—type 2 diabetes mellitus	0.000151	0.000646	CcSEcCtD
Thiotepa—Dyspepsia—Gliclazide—type 2 diabetes mellitus	0.000151	0.000646	CcSEcCtD
Thiotepa—Anorexia—Valsartan—type 2 diabetes mellitus	0.00015	0.000642	CcSEcCtD
Thiotepa—Asthenia—Bromocriptine—type 2 diabetes mellitus	0.00015	0.000641	CcSEcCtD
Thiotepa—Myalgia—Metformin—type 2 diabetes mellitus	0.00015	0.00064	CcSEcCtD
Thiotepa—Headache—Pioglitazone—type 2 diabetes mellitus	0.000149	0.000637	CcSEcCtD
Thiotepa—Unspecified disorder of skin and subcutaneous tissue—Metformin—type 2 diabetes mellitus	0.000149	0.000636	CcSEcCtD
Thiotepa—Leukopenia—Irbesartan—type 2 diabetes mellitus	0.000149	0.000635	CcSEcCtD
Thiotepa—CYP3A4—Aflatoxin activation and detoxification—CYP1A2—type 2 diabetes mellitus	0.000148	0.0088	CbGpPWpGaD
Thiotepa—Gastrointestinal disorder—Gliclazide—type 2 diabetes mellitus	0.000148	0.000633	CcSEcCtD
Thiotepa—Fatigue—Gliclazide—type 2 diabetes mellitus	0.000148	0.000632	CcSEcCtD
Thiotepa—Nausea—Glipizide—type 2 diabetes mellitus	0.000148	0.00063	CcSEcCtD
Thiotepa—Vomiting—Glimepiride—type 2 diabetes mellitus	0.000147	0.00063	CcSEcCtD
Thiotepa—Vision blurred—Losartan—type 2 diabetes mellitus	0.000147	0.000629	CcSEcCtD
Thiotepa—Vomiting—Sitagliptin—type 2 diabetes mellitus	0.000147	0.000628	CcSEcCtD
Thiotepa—Pain—Gliclazide—type 2 diabetes mellitus	0.000147	0.000627	CcSEcCtD
Thiotepa—Constipation—Gliclazide—type 2 diabetes mellitus	0.000147	0.000627	CcSEcCtD
Thiotepa—Rash—Glimepiride—type 2 diabetes mellitus	0.000146	0.000624	CcSEcCtD
Thiotepa—Dermatitis—Glimepiride—type 2 diabetes mellitus	0.000146	0.000624	CcSEcCtD
Thiotepa—Rash—Sitagliptin—type 2 diabetes mellitus	0.000146	0.000623	CcSEcCtD
Thiotepa—Dermatitis—Sitagliptin—type 2 diabetes mellitus	0.000146	0.000622	CcSEcCtD
Thiotepa—CYP3A4—Constitutive Androstane Receptor Pathway—ABCC2—type 2 diabetes mellitus	0.000145	0.00863	CbGpPWpGaD
Thiotepa—Headache—Glimepiride—type 2 diabetes mellitus	0.000145	0.00062	CcSEcCtD
Thiotepa—Cough—Irbesartan—type 2 diabetes mellitus	0.000145	0.000619	CcSEcCtD
Thiotepa—Headache—Sitagliptin—type 2 diabetes mellitus	0.000145	0.000619	CcSEcCtD
Thiotepa—Anaemia—Losartan—type 2 diabetes mellitus	0.000144	0.000617	CcSEcCtD
Thiotepa—CYP3A4—Xenobiotics—CYP2E1—type 2 diabetes mellitus	0.000144	0.00855	CbGpPWpGaD
Thiotepa—Musculoskeletal discomfort—Valsartan—type 2 diabetes mellitus	0.000144	0.000614	CcSEcCtD
Thiotepa—Agitation—Losartan—type 2 diabetes mellitus	0.000144	0.000614	CcSEcCtD
Thiotepa—Tinnitus—Ramipril—type 2 diabetes mellitus	0.000144	0.000613	CcSEcCtD
Thiotepa—Hypertension—Irbesartan—type 2 diabetes mellitus	0.000143	0.000613	CcSEcCtD
Thiotepa—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	0.000143	0.000611	CcSEcCtD
Thiotepa—Infection—Metformin—type 2 diabetes mellitus	0.000143	0.00061	CcSEcCtD
Thiotepa—CYP3A4—Xenobiotics—CYP1A2—type 2 diabetes mellitus	0.000142	0.00845	CbGpPWpGaD
Thiotepa—Musculoskeletal discomfort—Orlistat—type 2 diabetes mellitus	0.000142	0.000607	CcSEcCtD
Thiotepa—Paraesthesia—Valsartan—type 2 diabetes mellitus	0.000142	0.000605	CcSEcCtD
Thiotepa—Feeling abnormal—Gliclazide—type 2 diabetes mellitus	0.000141	0.000604	CcSEcCtD
Thiotepa—Arthralgia—Irbesartan—type 2 diabetes mellitus	0.000141	0.000604	CcSEcCtD
Thiotepa—Myalgia—Irbesartan—type 2 diabetes mellitus	0.000141	0.000604	CcSEcCtD
Thiotepa—Anxiety—Irbesartan—type 2 diabetes mellitus	0.000141	0.000602	CcSEcCtD
Thiotepa—Hypersensitivity—Glyburide—type 2 diabetes mellitus	0.000141	0.000602	CcSEcCtD
Thiotepa—Nervous system disorder—Metformin—type 2 diabetes mellitus	0.000141	0.000602	CcSEcCtD
Thiotepa—Thrombocytopenia—Metformin—type 2 diabetes mellitus	0.000141	0.000601	CcSEcCtD
Thiotepa—Unspecified disorder of skin and subcutaneous tissue—Irbesartan—type 2 diabetes mellitus	0.00014	0.0006	CcSEcCtD
Thiotepa—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	0.00014	0.0006	CcSEcCtD
Thiotepa—Somnolence—Valsartan—type 2 diabetes mellitus	0.00014	0.000599	CcSEcCtD
Thiotepa—Paraesthesia—Orlistat—type 2 diabetes mellitus	0.00014	0.000598	CcSEcCtD
Thiotepa—Leukopenia—Losartan—type 2 diabetes mellitus	0.00014	0.000598	CcSEcCtD
Thiotepa—CYP2B6—Biological oxidations—MAT1A—type 2 diabetes mellitus	0.00014	0.00829	CbGpPWpGaD
Thiotepa—Skin disorder—Metformin—type 2 diabetes mellitus	0.00014	0.000596	CcSEcCtD
Thiotepa—Immune system disorder—Ramipril—type 2 diabetes mellitus	0.000139	0.000594	CcSEcCtD
Thiotepa—Dyspepsia—Valsartan—type 2 diabetes mellitus	0.000139	0.000593	CcSEcCtD
Thiotepa—Mediastinal disorder—Ramipril—type 2 diabetes mellitus	0.000139	0.000593	CcSEcCtD
Thiotepa—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCC2—type 2 diabetes mellitus	0.000139	0.00822	CbGpPWpGaD
Thiotepa—CYP3A4—Tamoxifen metabolism—CYP2E1—type 2 diabetes mellitus	0.000138	0.00822	CbGpPWpGaD
Thiotepa—Dizziness—Bromocriptine—type 2 diabetes mellitus	0.000138	0.000591	CcSEcCtD
Thiotepa—Nausea—Glimepiride—type 2 diabetes mellitus	0.000138	0.000588	CcSEcCtD
Thiotepa—Arrhythmia—Ramipril—type 2 diabetes mellitus	0.000138	0.000588	CcSEcCtD
Thiotepa—Nausea—Sitagliptin—type 2 diabetes mellitus	0.000137	0.000586	CcSEcCtD
Thiotepa—Dyspepsia—Orlistat—type 2 diabetes mellitus	0.000137	0.000586	CcSEcCtD
Thiotepa—Asthenia—Glyburide—type 2 diabetes mellitus	0.000137	0.000586	CcSEcCtD
Thiotepa—Decreased appetite—Valsartan—type 2 diabetes mellitus	0.000137	0.000586	CcSEcCtD
Thiotepa—CYP3A4—Tamoxifen metabolism—CYP1A2—type 2 diabetes mellitus	0.000137	0.00813	CbGpPWpGaD
Thiotepa—Anorexia—Metformin—type 2 diabetes mellitus	0.000137	0.000585	CcSEcCtD
Thiotepa—Cough—Losartan—type 2 diabetes mellitus	0.000136	0.000583	CcSEcCtD
Thiotepa—Urticaria—Gliclazide—type 2 diabetes mellitus	0.000136	0.000583	CcSEcCtD
Thiotepa—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—type 2 diabetes mellitus	0.000136	0.00808	CbGpPWpGaD
Thiotepa—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	0.000136	0.000582	CcSEcCtD
Thiotepa—Alopecia—Ramipril—type 2 diabetes mellitus	0.000136	0.000581	CcSEcCtD
Thiotepa—Fatigue—Valsartan—type 2 diabetes mellitus	0.000136	0.000581	CcSEcCtD
Thiotepa—Body temperature increased—Gliclazide—type 2 diabetes mellitus	0.000136	0.00058	CcSEcCtD
Thiotepa—Abdominal pain—Gliclazide—type 2 diabetes mellitus	0.000136	0.00058	CcSEcCtD
Thiotepa—Decreased appetite—Orlistat—type 2 diabetes mellitus	0.000135	0.000579	CcSEcCtD
Thiotepa—Pruritus—Glyburide—type 2 diabetes mellitus	0.000135	0.000578	CcSEcCtD
Thiotepa—Mental disorder—Ramipril—type 2 diabetes mellitus	0.000135	0.000576	CcSEcCtD
Thiotepa—Constipation—Valsartan—type 2 diabetes mellitus	0.000135	0.000576	CcSEcCtD
Thiotepa—Infection—Irbesartan—type 2 diabetes mellitus	0.000135	0.000575	CcSEcCtD
Thiotepa—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	0.000135	0.000575	CcSEcCtD
Thiotepa—Fatigue—Orlistat—type 2 diabetes mellitus	0.000134	0.000574	CcSEcCtD
Thiotepa—Erythema—Ramipril—type 2 diabetes mellitus	0.000134	0.000573	CcSEcCtD
Thiotepa—Malnutrition—Ramipril—type 2 diabetes mellitus	0.000134	0.000573	CcSEcCtD
Thiotepa—Pain—Orlistat—type 2 diabetes mellitus	0.000133	0.000569	CcSEcCtD
Thiotepa—Arthralgia—Losartan—type 2 diabetes mellitus	0.000133	0.000569	CcSEcCtD
Thiotepa—Myalgia—Losartan—type 2 diabetes mellitus	0.000133	0.000569	CcSEcCtD
Thiotepa—Vomiting—Bromocriptine—type 2 diabetes mellitus	0.000133	0.000568	CcSEcCtD
Thiotepa—Nervous system disorder—Irbesartan—type 2 diabetes mellitus	0.000133	0.000568	CcSEcCtD
Thiotepa—Thrombocytopenia—Irbesartan—type 2 diabetes mellitus	0.000133	0.000567	CcSEcCtD
Thiotepa—Anxiety—Losartan—type 2 diabetes mellitus	0.000133	0.000567	CcSEcCtD
Thiotepa—Tachycardia—Irbesartan—type 2 diabetes mellitus	0.000132	0.000565	CcSEcCtD
Thiotepa—Rash—Bromocriptine—type 2 diabetes mellitus	0.000132	0.000563	CcSEcCtD
Thiotepa—Dermatitis—Bromocriptine—type 2 diabetes mellitus	0.000132	0.000563	CcSEcCtD
Thiotepa—Skin disorder—Irbesartan—type 2 diabetes mellitus	0.000132	0.000562	CcSEcCtD
Thiotepa—CYP2B6—Cytochrome P450 - arranged by substrate type—CYP2E1—type 2 diabetes mellitus	0.000132	0.00781	CbGpPWpGaD
Thiotepa—Tension—Ramipril—type 2 diabetes mellitus	0.000132	0.000562	CcSEcCtD
Thiotepa—Headache—Bromocriptine—type 2 diabetes mellitus	0.000131	0.00056	CcSEcCtD
Thiotepa—Musculoskeletal discomfort—Metformin—type 2 diabetes mellitus	0.000131	0.000559	CcSEcCtD
Thiotepa—Diarrhoea—Glyburide—type 2 diabetes mellitus	0.000131	0.000559	CcSEcCtD
Thiotepa—Nervousness—Ramipril—type 2 diabetes mellitus	0.00013	0.000556	CcSEcCtD
Thiotepa—CYP2B6—Cytochrome P450 - arranged by substrate type—CYP1A2—type 2 diabetes mellitus	0.00013	0.00772	CbGpPWpGaD
Thiotepa—CYP2B6—Oxidation by Cytochrome P450—CYP2E1—type 2 diabetes mellitus	0.00013	0.00771	CbGpPWpGaD
Thiotepa—CYP2B6—Phase 1 - Functionalization of compounds—CYP11A1—type 2 diabetes mellitus	0.000129	0.00767	CbGpPWpGaD
Thiotepa—Anorexia—Irbesartan—type 2 diabetes mellitus	0.000129	0.000552	CcSEcCtD
Thiotepa—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	0.000129	0.000551	CcSEcCtD
Thiotepa—Paraesthesia—Metformin—type 2 diabetes mellitus	0.000129	0.000551	CcSEcCtD
Thiotepa—Confusional state—Losartan—type 2 diabetes mellitus	0.000129	0.00055	CcSEcCtD
Thiotepa—Feeling abnormal—Orlistat—type 2 diabetes mellitus	0.000128	0.000549	CcSEcCtD
Thiotepa—CYP2B6—Oxidation by Cytochrome P450—CYP1A2—type 2 diabetes mellitus	0.000128	0.00762	CbGpPWpGaD
Thiotepa—Somnolence—Metformin—type 2 diabetes mellitus	0.000128	0.000546	CcSEcCtD
Thiotepa—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	0.000127	0.000544	CcSEcCtD
Thiotepa—CYP2B6—Cytochrome P450 - arranged by substrate type—CYP3A4—type 2 diabetes mellitus	0.000127	0.00753	CbGpPWpGaD
Thiotepa—Infection—Losartan—type 2 diabetes mellitus	0.000127	0.000541	CcSEcCtD
Thiotepa—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	0.000126	0.00054	CcSEcCtD
Thiotepa—Dyspepsia—Metformin—type 2 diabetes mellitus	0.000126	0.00054	CcSEcCtD
Thiotepa—Urticaria—Valsartan—type 2 diabetes mellitus	0.000125	0.000535	CcSEcCtD
Thiotepa—CYP2B6—Oxidation by Cytochrome P450—CYP3A4—type 2 diabetes mellitus	0.000125	0.00743	CbGpPWpGaD
Thiotepa—Nervous system disorder—Losartan—type 2 diabetes mellitus	0.000125	0.000534	CcSEcCtD
Thiotepa—Thrombocytopenia—Losartan—type 2 diabetes mellitus	0.000125	0.000534	CcSEcCtD
Thiotepa—Decreased appetite—Metformin—type 2 diabetes mellitus	0.000125	0.000533	CcSEcCtD
Thiotepa—Abdominal pain—Valsartan—type 2 diabetes mellitus	0.000125	0.000533	CcSEcCtD
Thiotepa—Tachycardia—Losartan—type 2 diabetes mellitus	0.000124	0.000532	CcSEcCtD
Thiotepa—Nausea—Bromocriptine—type 2 diabetes mellitus	0.000124	0.000531	CcSEcCtD
Thiotepa—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	0.000124	0.00053	CcSEcCtD
Thiotepa—Fatigue—Metformin—type 2 diabetes mellitus	0.000124	0.000529	CcSEcCtD
Thiotepa—Urticaria—Orlistat—type 2 diabetes mellitus	0.000124	0.000529	CcSEcCtD
Thiotepa—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	0.000123	0.000528	CcSEcCtD
Thiotepa—Abdominal pain—Orlistat—type 2 diabetes mellitus	0.000123	0.000526	CcSEcCtD
Thiotepa—Body temperature increased—Orlistat—type 2 diabetes mellitus	0.000123	0.000526	CcSEcCtD
Thiotepa—Asthenia—Gliclazide—type 2 diabetes mellitus	0.000123	0.000526	CcSEcCtD
Thiotepa—Agitation—Ramipril—type 2 diabetes mellitus	0.000123	0.000526	CcSEcCtD
Thiotepa—Constipation—Metformin—type 2 diabetes mellitus	0.000123	0.000525	CcSEcCtD
Thiotepa—CYP3A4—Farnesoid X Receptor  Pathway—PPARGC1A—type 2 diabetes mellitus	0.000123	0.00728	CbGpPWpGaD
Thiotepa—Paraesthesia—Irbesartan—type 2 diabetes mellitus	0.000122	0.00052	CcSEcCtD
Thiotepa—Anorexia—Losartan—type 2 diabetes mellitus	0.000122	0.000519	CcSEcCtD
Thiotepa—Vomiting—Glyburide—type 2 diabetes mellitus	0.000122	0.000519	CcSEcCtD
Thiotepa—Pruritus—Gliclazide—type 2 diabetes mellitus	0.000121	0.000519	CcSEcCtD
Thiotepa—Rash—Glyburide—type 2 diabetes mellitus	0.000121	0.000515	CcSEcCtD
Thiotepa—Somnolence—Irbesartan—type 2 diabetes mellitus	0.00012	0.000515	CcSEcCtD
Thiotepa—Dermatitis—Glyburide—type 2 diabetes mellitus	0.00012	0.000515	CcSEcCtD
Thiotepa—Leukopenia—Ramipril—type 2 diabetes mellitus	0.00012	0.000513	CcSEcCtD
Thiotepa—Headache—Glyburide—type 2 diabetes mellitus	0.00012	0.000512	CcSEcCtD
Thiotepa—Dyspepsia—Irbesartan—type 2 diabetes mellitus	0.000119	0.00051	CcSEcCtD
Thiotepa—CYP3A4—Estrogen metabolism—GSTM1—type 2 diabetes mellitus	0.000119	0.00705	CbGpPWpGaD
Thiotepa—Feeling abnormal—Metformin—type 2 diabetes mellitus	0.000118	0.000506	CcSEcCtD
Thiotepa—Decreased appetite—Irbesartan—type 2 diabetes mellitus	0.000118	0.000503	CcSEcCtD
Thiotepa—Diarrhoea—Gliclazide—type 2 diabetes mellitus	0.000117	0.000502	CcSEcCtD
Thiotepa—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	0.000117	0.000502	CcSEcCtD
Thiotepa—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	0.000117	0.0005	CcSEcCtD
Thiotepa—Cough—Ramipril—type 2 diabetes mellitus	0.000117	0.0005	CcSEcCtD
Thiotepa—Fatigue—Irbesartan—type 2 diabetes mellitus	0.000117	0.000499	CcSEcCtD
Thiotepa—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	0.000116	0.000497	CcSEcCtD
Thiotepa—Hypersensitivity—Valsartan—type 2 diabetes mellitus	0.000116	0.000496	CcSEcCtD
Thiotepa—Convulsion—Ramipril—type 2 diabetes mellitus	0.000116	0.000496	CcSEcCtD
Thiotepa—Pain—Irbesartan—type 2 diabetes mellitus	0.000116	0.000495	CcSEcCtD
Thiotepa—Constipation—Irbesartan—type 2 diabetes mellitus	0.000116	0.000495	CcSEcCtD
Thiotepa—Hypersensitivity—Orlistat—type 2 diabetes mellitus	0.000115	0.000491	CcSEcCtD
Thiotepa—Paraesthesia—Losartan—type 2 diabetes mellitus	0.000115	0.000489	CcSEcCtD
Thiotepa—Urticaria—Metformin—type 2 diabetes mellitus	0.000114	0.000487	CcSEcCtD
Thiotepa—Myalgia—Ramipril—type 2 diabetes mellitus	0.000114	0.000487	CcSEcCtD
Thiotepa—Arthralgia—Ramipril—type 2 diabetes mellitus	0.000114	0.000487	CcSEcCtD
Thiotepa—Anxiety—Ramipril—type 2 diabetes mellitus	0.000114	0.000486	CcSEcCtD
Thiotepa—Nausea—Glyburide—type 2 diabetes mellitus	0.000114	0.000485	CcSEcCtD
Thiotepa—Abdominal pain—Metformin—type 2 diabetes mellitus	0.000114	0.000485	CcSEcCtD
Thiotepa—Dizziness—Gliclazide—type 2 diabetes mellitus	0.000114	0.000485	CcSEcCtD
Thiotepa—Somnolence—Losartan—type 2 diabetes mellitus	0.000113	0.000484	CcSEcCtD
Thiotepa—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 2 diabetes mellitus	0.000113	0.000484	CcSEcCtD
Thiotepa—Asthenia—Valsartan—type 2 diabetes mellitus	0.000113	0.000483	CcSEcCtD
Thiotepa—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—type 2 diabetes mellitus	0.000113	0.00668	CbGpPWpGaD
Thiotepa—Dyspepsia—Losartan—type 2 diabetes mellitus	0.000112	0.00048	CcSEcCtD
Thiotepa—Asthenia—Orlistat—type 2 diabetes mellitus	0.000112	0.000478	CcSEcCtD
Thiotepa—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	0.000112	0.000477	CcSEcCtD
Thiotepa—Pruritus—Valsartan—type 2 diabetes mellitus	0.000112	0.000477	CcSEcCtD
Thiotepa—Decreased appetite—Losartan—type 2 diabetes mellitus	0.000111	0.000474	CcSEcCtD
Thiotepa—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	0.000111	0.000474	CcSEcCtD
Thiotepa—Confusional state—Ramipril—type 2 diabetes mellitus	0.00011	0.000471	CcSEcCtD
Thiotepa—Pruritus—Orlistat—type 2 diabetes mellitus	0.00011	0.000471	CcSEcCtD
Thiotepa—Fatigue—Losartan—type 2 diabetes mellitus	0.00011	0.00047	CcSEcCtD
Thiotepa—Vomiting—Gliclazide—type 2 diabetes mellitus	0.000109	0.000466	CcSEcCtD
Thiotepa—Pain—Losartan—type 2 diabetes mellitus	0.000109	0.000466	CcSEcCtD
Thiotepa—Constipation—Losartan—type 2 diabetes mellitus	0.000109	0.000466	CcSEcCtD
Thiotepa—Rash—Gliclazide—type 2 diabetes mellitus	0.000108	0.000462	CcSEcCtD
Thiotepa—Dermatitis—Gliclazide—type 2 diabetes mellitus	0.000108	0.000462	CcSEcCtD
Thiotepa—Diarrhoea—Valsartan—type 2 diabetes mellitus	0.000108	0.000461	CcSEcCtD
Thiotepa—Urticaria—Irbesartan—type 2 diabetes mellitus	0.000108	0.00046	CcSEcCtD
Thiotepa—Headache—Gliclazide—type 2 diabetes mellitus	0.000108	0.000459	CcSEcCtD
Thiotepa—Nervous system disorder—Ramipril—type 2 diabetes mellitus	0.000107	0.000458	CcSEcCtD
Thiotepa—Abdominal pain—Irbesartan—type 2 diabetes mellitus	0.000107	0.000458	CcSEcCtD
Thiotepa—Body temperature increased—Irbesartan—type 2 diabetes mellitus	0.000107	0.000458	CcSEcCtD
Thiotepa—Thrombocytopenia—Ramipril—type 2 diabetes mellitus	0.000107	0.000458	CcSEcCtD
Thiotepa—Tachycardia—Ramipril—type 2 diabetes mellitus	0.000107	0.000456	CcSEcCtD
Thiotepa—CYP2B6—Phase 1 - Functionalization of compounds—CYP2E1—type 2 diabetes mellitus	0.000107	0.00633	CbGpPWpGaD
Thiotepa—Diarrhoea—Orlistat—type 2 diabetes mellitus	0.000107	0.000456	CcSEcCtD
Thiotepa—Skin disorder—Ramipril—type 2 diabetes mellitus	0.000106	0.000454	CcSEcCtD
Thiotepa—CYP2B6—Phase 1 - Functionalization of compounds—CYP1A2—type 2 diabetes mellitus	0.000105	0.00626	CbGpPWpGaD
Thiotepa—Feeling abnormal—Losartan—type 2 diabetes mellitus	0.000105	0.000449	CcSEcCtD
Thiotepa—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	0.000104	0.000446	CcSEcCtD
Thiotepa—Dizziness—Valsartan—type 2 diabetes mellitus	0.000104	0.000446	CcSEcCtD
Thiotepa—Anorexia—Ramipril—type 2 diabetes mellitus	0.000104	0.000445	CcSEcCtD
Thiotepa—Dizziness—Orlistat—type 2 diabetes mellitus	0.000103	0.00044	CcSEcCtD
Thiotepa—Asthenia—Metformin—type 2 diabetes mellitus	0.000103	0.00044	CcSEcCtD
Thiotepa—CYP2B6—Phase 1 - Functionalization of compounds—CYP3A4—type 2 diabetes mellitus	0.000103	0.0061	CbGpPWpGaD
Thiotepa—Nausea—Gliclazide—type 2 diabetes mellitus	0.000102	0.000436	CcSEcCtD
Thiotepa—Pruritus—Metformin—type 2 diabetes mellitus	0.000102	0.000434	CcSEcCtD
Thiotepa—Urticaria—Losartan—type 2 diabetes mellitus	0.000101	0.000433	CcSEcCtD
Thiotepa—Body temperature increased—Losartan—type 2 diabetes mellitus	0.000101	0.000431	CcSEcCtD
Thiotepa—Abdominal pain—Losartan—type 2 diabetes mellitus	0.000101	0.000431	CcSEcCtD
Thiotepa—Vomiting—Valsartan—type 2 diabetes mellitus	0.0001	0.000428	CcSEcCtD
Thiotepa—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	9.99e-05	0.000427	CcSEcCtD
Thiotepa—Musculoskeletal discomfort—Ramipril—type 2 diabetes mellitus	9.97e-05	0.000426	CcSEcCtD
Thiotepa—Rash—Valsartan—type 2 diabetes mellitus	9.94e-05	0.000425	CcSEcCtD
Thiotepa—Dermatitis—Valsartan—type 2 diabetes mellitus	9.94e-05	0.000424	CcSEcCtD
Thiotepa—Vomiting—Orlistat—type 2 diabetes mellitus	9.91e-05	0.000423	CcSEcCtD
Thiotepa—Headache—Valsartan—type 2 diabetes mellitus	9.88e-05	0.000422	CcSEcCtD
Thiotepa—Diarrhoea—Metformin—type 2 diabetes mellitus	9.83e-05	0.00042	CcSEcCtD
Thiotepa—Rash—Orlistat—type 2 diabetes mellitus	9.83e-05	0.00042	CcSEcCtD
Thiotepa—Paraesthesia—Ramipril—type 2 diabetes mellitus	9.82e-05	0.00042	CcSEcCtD
Thiotepa—Dermatitis—Orlistat—type 2 diabetes mellitus	9.82e-05	0.000419	CcSEcCtD
Thiotepa—Headache—Orlistat—type 2 diabetes mellitus	9.76e-05	0.000417	CcSEcCtD
Thiotepa—Asthenia—Irbesartan—type 2 diabetes mellitus	9.72e-05	0.000415	CcSEcCtD
Thiotepa—Somnolence—Ramipril—type 2 diabetes mellitus	9.72e-05	0.000415	CcSEcCtD
Thiotepa—Dyspepsia—Ramipril—type 2 diabetes mellitus	9.63e-05	0.000411	CcSEcCtD
Thiotepa—Pruritus—Irbesartan—type 2 diabetes mellitus	9.59e-05	0.00041	CcSEcCtD
Thiotepa—CYP3A4—Farnesoid X Receptor  Pathway—IRS2—type 2 diabetes mellitus	9.56e-05	0.00567	CbGpPWpGaD
Thiotepa—Decreased appetite—Ramipril—type 2 diabetes mellitus	9.51e-05	0.000406	CcSEcCtD
Thiotepa—Dizziness—Metformin—type 2 diabetes mellitus	9.5e-05	0.000406	CcSEcCtD
Thiotepa—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	9.44e-05	0.000403	CcSEcCtD
Thiotepa—Fatigue—Ramipril—type 2 diabetes mellitus	9.43e-05	0.000403	CcSEcCtD
Thiotepa—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2E1—type 2 diabetes mellitus	9.42e-05	0.00559	CbGpPWpGaD
Thiotepa—Hypersensitivity—Losartan—type 2 diabetes mellitus	9.4e-05	0.000402	CcSEcCtD
Thiotepa—Nausea—Valsartan—type 2 diabetes mellitus	9.37e-05	0.0004	CcSEcCtD
Thiotepa—Constipation—Ramipril—type 2 diabetes mellitus	9.35e-05	0.0004	CcSEcCtD
Thiotepa—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP1A2—type 2 diabetes mellitus	9.31e-05	0.00553	CbGpPWpGaD
Thiotepa—Diarrhoea—Irbesartan—type 2 diabetes mellitus	9.27e-05	0.000396	CcSEcCtD
Thiotepa—Nausea—Orlistat—type 2 diabetes mellitus	9.26e-05	0.000396	CcSEcCtD
Thiotepa—Asthenia—Losartan—type 2 diabetes mellitus	9.15e-05	0.000391	CcSEcCtD
Thiotepa—Vomiting—Metformin—type 2 diabetes mellitus	9.13e-05	0.00039	CcSEcCtD
Thiotepa—Rash—Metformin—type 2 diabetes mellitus	9.06e-05	0.000387	CcSEcCtD
Thiotepa—Dermatitis—Metformin—type 2 diabetes mellitus	9.05e-05	0.000387	CcSEcCtD
Thiotepa—Pruritus—Losartan—type 2 diabetes mellitus	9.02e-05	0.000386	CcSEcCtD
Thiotepa—Feeling abnormal—Ramipril—type 2 diabetes mellitus	9.01e-05	0.000385	CcSEcCtD
Thiotepa—Headache—Metformin—type 2 diabetes mellitus	9e-05	0.000384	CcSEcCtD
Thiotepa—Dizziness—Irbesartan—type 2 diabetes mellitus	8.96e-05	0.000383	CcSEcCtD
Thiotepa—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	8.94e-05	0.000382	CcSEcCtD
Thiotepa—Diarrhoea—Losartan—type 2 diabetes mellitus	8.73e-05	0.000373	CcSEcCtD
Thiotepa—Urticaria—Ramipril—type 2 diabetes mellitus	8.69e-05	0.000371	CcSEcCtD
Thiotepa—Abdominal pain—Ramipril—type 2 diabetes mellitus	8.65e-05	0.000369	CcSEcCtD
Thiotepa—Body temperature increased—Ramipril—type 2 diabetes mellitus	8.65e-05	0.000369	CcSEcCtD
Thiotepa—Vomiting—Irbesartan—type 2 diabetes mellitus	8.62e-05	0.000368	CcSEcCtD
Thiotepa—Rash—Irbesartan—type 2 diabetes mellitus	8.55e-05	0.000365	CcSEcCtD
Thiotepa—Dermatitis—Irbesartan—type 2 diabetes mellitus	8.54e-05	0.000365	CcSEcCtD
Thiotepa—Nausea—Metformin—type 2 diabetes mellitus	8.53e-05	0.000364	CcSEcCtD
Thiotepa—Headache—Irbesartan—type 2 diabetes mellitus	8.49e-05	0.000363	CcSEcCtD
Thiotepa—Dizziness—Losartan—type 2 diabetes mellitus	8.44e-05	0.00036	CcSEcCtD
Thiotepa—Vomiting—Losartan—type 2 diabetes mellitus	8.11e-05	0.000347	CcSEcCtD
Thiotepa—CYP3A4—Constitutive Androstane Receptor Pathway—PPARGC1A—type 2 diabetes mellitus	8.08e-05	0.00479	CbGpPWpGaD
Thiotepa—Hypersensitivity—Ramipril—type 2 diabetes mellitus	8.06e-05	0.000344	CcSEcCtD
Thiotepa—Nausea—Irbesartan—type 2 diabetes mellitus	8.05e-05	0.000344	CcSEcCtD
Thiotepa—Rash—Losartan—type 2 diabetes mellitus	8.04e-05	0.000344	CcSEcCtD
Thiotepa—Dermatitis—Losartan—type 2 diabetes mellitus	8.04e-05	0.000343	CcSEcCtD
Thiotepa—Headache—Losartan—type 2 diabetes mellitus	7.99e-05	0.000341	CcSEcCtD
Thiotepa—Asthenia—Ramipril—type 2 diabetes mellitus	7.85e-05	0.000335	CcSEcCtD
Thiotepa—Pruritus—Ramipril—type 2 diabetes mellitus	7.74e-05	0.000331	CcSEcCtD
Thiotepa—Nausea—Losartan—type 2 diabetes mellitus	7.58e-05	0.000324	CcSEcCtD
Thiotepa—Diarrhoea—Ramipril—type 2 diabetes mellitus	7.48e-05	0.00032	CcSEcCtD
Thiotepa—CYP3A4—Tryptophan metabolism—CYP2E1—type 2 diabetes mellitus	7.4e-05	0.00439	CbGpPWpGaD
Thiotepa—CYP3A4—Tryptophan metabolism—CYP1A2—type 2 diabetes mellitus	7.31e-05	0.00434	CbGpPWpGaD
Thiotepa—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP11A1—type 2 diabetes mellitus	7.24e-05	0.0043	CbGpPWpGaD
Thiotepa—Dizziness—Ramipril—type 2 diabetes mellitus	7.23e-05	0.000309	CcSEcCtD
Thiotepa—CYP3A4—Oxidation by Cytochrome P450—CYP11A1—type 2 diabetes mellitus	7.15e-05	0.00424	CbGpPWpGaD
Thiotepa—CYP2B6—Biological oxidations—MTR—type 2 diabetes mellitus	7.09e-05	0.00421	CbGpPWpGaD
Thiotepa—Vomiting—Ramipril—type 2 diabetes mellitus	6.95e-05	0.000297	CcSEcCtD
Thiotepa—Rash—Ramipril—type 2 diabetes mellitus	6.9e-05	0.000295	CcSEcCtD
Thiotepa—Dermatitis—Ramipril—type 2 diabetes mellitus	6.89e-05	0.000294	CcSEcCtD
Thiotepa—CYP2B6—Biological oxidations—CYP11A1—type 2 diabetes mellitus	6.86e-05	0.00407	CbGpPWpGaD
Thiotepa—Headache—Ramipril—type 2 diabetes mellitus	6.85e-05	0.000293	CcSEcCtD
Thiotepa—CYP2B6—Metapathway biotransformation—CYP11A1—type 2 diabetes mellitus	6.77e-05	0.00402	CbGpPWpGaD
Thiotepa—Nausea—Ramipril—type 2 diabetes mellitus	6.5e-05	0.000278	CcSEcCtD
Thiotepa—CYP3A4—Biological oxidations—MAT1A—type 2 diabetes mellitus	6.35e-05	0.00377	CbGpPWpGaD
Thiotepa—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—type 2 diabetes mellitus	6.19e-05	0.00367	CbGpPWpGaD
Thiotepa—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2E1—type 2 diabetes mellitus	5.98e-05	0.00355	CbGpPWpGaD
Thiotepa—CYP3A4—Tryptophan metabolism—CAT—type 2 diabetes mellitus	5.94e-05	0.00352	CbGpPWpGaD
Thiotepa—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A2—type 2 diabetes mellitus	5.91e-05	0.00351	CbGpPWpGaD
Thiotepa—CYP3A4—Oxidation by Cytochrome P450—CYP2E1—type 2 diabetes mellitus	5.9e-05	0.0035	CbGpPWpGaD
Thiotepa—CYP3A4—Phase 1 - Functionalization of compounds—CYP11A1—type 2 diabetes mellitus	5.87e-05	0.00349	CbGpPWpGaD
Thiotepa—CYP3A4—Oxidation by Cytochrome P450—CYP1A2—type 2 diabetes mellitus	5.83e-05	0.00346	CbGpPWpGaD
Thiotepa—CYP2B6—Biological oxidations—CYP2E1—type 2 diabetes mellitus	5.67e-05	0.00336	CbGpPWpGaD
Thiotepa—CYP2B6—Biological oxidations—CYP1A2—type 2 diabetes mellitus	5.6e-05	0.00333	CbGpPWpGaD
Thiotepa—CYP2B6—Metapathway biotransformation—CYP2E1—type 2 diabetes mellitus	5.59e-05	0.00332	CbGpPWpGaD
Thiotepa—CYP2B6—Metapathway biotransformation—CYP1A2—type 2 diabetes mellitus	5.53e-05	0.00328	CbGpPWpGaD
Thiotepa—CYP2B6—Biological oxidations—CYP3A4—type 2 diabetes mellitus	5.46e-05	0.00324	CbGpPWpGaD
Thiotepa—CYP2B6—Metapathway biotransformation—CYP3A4—type 2 diabetes mellitus	5.39e-05	0.0032	CbGpPWpGaD
Thiotepa—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—type 2 diabetes mellitus	5.12e-05	0.00304	CbGpPWpGaD
Thiotepa—CYP3A4—Phase 1 - Functionalization of compounds—CYP2E1—type 2 diabetes mellitus	4.85e-05	0.00288	CbGpPWpGaD
Thiotepa—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A2—type 2 diabetes mellitus	4.79e-05	0.00284	CbGpPWpGaD
Thiotepa—CYP2B6—Biological oxidations—GSTM1—type 2 diabetes mellitus	4.29e-05	0.00255	CbGpPWpGaD
Thiotepa—CYP2B6—Metapathway biotransformation—GSTM1—type 2 diabetes mellitus	4.24e-05	0.00251	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—BHMT—type 2 diabetes mellitus	3.28e-05	0.00194	CbGpPWpGaD
Thiotepa—CYP3A4—Biological oxidations—MTR—type 2 diabetes mellitus	3.22e-05	0.00191	CbGpPWpGaD
Thiotepa—CYP3A4—Biological oxidations—CYP11A1—type 2 diabetes mellitus	3.12e-05	0.00185	CbGpPWpGaD
Thiotepa—CYP3A4—Metapathway biotransformation—CYP11A1—type 2 diabetes mellitus	3.08e-05	0.00183	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—PTGDS—type 2 diabetes mellitus	2.86e-05	0.0017	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—AANAT—type 2 diabetes mellitus	2.86e-05	0.0017	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—CDO1—type 2 diabetes mellitus	2.71e-05	0.00161	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—GPD2—type 2 diabetes mellitus	2.71e-05	0.00161	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—AK1—type 2 diabetes mellitus	2.59e-05	0.00154	CbGpPWpGaD
Thiotepa—CYP3A4—Biological oxidations—CYP2E1—type 2 diabetes mellitus	2.57e-05	0.00153	CbGpPWpGaD
Thiotepa—CYP3A4—Biological oxidations—CYP1A2—type 2 diabetes mellitus	2.55e-05	0.00151	CbGpPWpGaD
Thiotepa—CYP3A4—Metapathway biotransformation—CYP2E1—type 2 diabetes mellitus	2.54e-05	0.00151	CbGpPWpGaD
Thiotepa—CYP3A4—Metapathway biotransformation—CYP1A2—type 2 diabetes mellitus	2.51e-05	0.00149	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—MAT1A—type 2 diabetes mellitus	2.39e-05	0.00142	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—SLC5A4—type 2 diabetes mellitus	2.39e-05	0.00142	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—PPP1R3C—type 2 diabetes mellitus	2.31e-05	0.00137	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—ND1—type 2 diabetes mellitus	2.31e-05	0.00137	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—G6PC—type 2 diabetes mellitus	2.31e-05	0.00137	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—ENPP1—type 2 diabetes mellitus	2.31e-05	0.00137	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—HBA2—type 2 diabetes mellitus	2.31e-05	0.00137	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—GCGR—type 2 diabetes mellitus	2.23e-05	0.00133	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—CYTB—type 2 diabetes mellitus	2.11e-05	0.00125	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—OXCT1—type 2 diabetes mellitus	2.11e-05	0.00125	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—SRD5A1—type 2 diabetes mellitus	2.06e-05	0.00122	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—ACACA—type 2 diabetes mellitus	1.96e-05	0.00116	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—HSD17B3—type 2 diabetes mellitus	1.96e-05	0.00116	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—STAR—type 2 diabetes mellitus	1.96e-05	0.00116	CbGpPWpGaD
Thiotepa—CYP3A4—Biological oxidations—GSTM1—type 2 diabetes mellitus	1.95e-05	0.00116	CbGpPWpGaD
Thiotepa—CYP3A4—Metapathway biotransformation—GSTM1—type 2 diabetes mellitus	1.92e-05	0.00114	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—ABCC8—type 2 diabetes mellitus	1.88e-05	0.00112	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—CBS—type 2 diabetes mellitus	1.88e-05	0.00112	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—COX2—type 2 diabetes mellitus	1.81e-05	0.00107	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—SLC5A2—type 2 diabetes mellitus	1.81e-05	0.00107	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—NCOA6—type 2 diabetes mellitus	1.78e-05	0.00106	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—HSD11B1—type 2 diabetes mellitus	1.75e-05	0.00104	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—UCP3—type 2 diabetes mellitus	1.75e-05	0.00104	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—UCP2—type 2 diabetes mellitus	1.75e-05	0.00104	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—PCK1—type 2 diabetes mellitus	1.64e-05	0.000976	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—HK1—type 2 diabetes mellitus	1.54e-05	0.000914	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—BHMT—type 2 diabetes mellitus	1.49e-05	0.000883	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—HSD3B2—type 2 diabetes mellitus	1.49e-05	0.000882	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—GCKR—type 2 diabetes mellitus	1.49e-05	0.000882	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—LPA—type 2 diabetes mellitus	1.49e-05	0.000882	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—KCNJ11—type 2 diabetes mellitus	1.49e-05	0.000882	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—ALDOB—type 2 diabetes mellitus	1.43e-05	0.000846	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—GLP1R—type 2 diabetes mellitus	1.33e-05	0.000787	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—AANAT—type 2 diabetes mellitus	1.3e-05	0.000772	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—PTGDS—type 2 diabetes mellitus	1.3e-05	0.000772	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—SLC2A2—type 2 diabetes mellitus	1.24e-05	0.000734	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—GPD2—type 2 diabetes mellitus	1.23e-05	0.000732	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—CDO1—type 2 diabetes mellitus	1.23e-05	0.000732	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—MTR—type 2 diabetes mellitus	1.21e-05	0.000719	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—CPT1A—type 2 diabetes mellitus	1.21e-05	0.000719	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—NAMPT—type 2 diabetes mellitus	1.19e-05	0.000705	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—GCK—type 2 diabetes mellitus	1.18e-05	0.000701	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—HBA1—type 2 diabetes mellitus	1.18e-05	0.000701	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—LIPC—type 2 diabetes mellitus	1.18e-05	0.000701	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—AK1—type 2 diabetes mellitus	1.18e-05	0.000698	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—CYP11A1—type 2 diabetes mellitus	1.17e-05	0.000697	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—SLC9A1—type 2 diabetes mellitus	1.15e-05	0.000684	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—CETP—type 2 diabetes mellitus	1.14e-05	0.000676	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—SLC5A4—type 2 diabetes mellitus	1.09e-05	0.000644	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—MAT1A—type 2 diabetes mellitus	1.09e-05	0.000644	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—SNAP25—type 2 diabetes mellitus	1.06e-05	0.000629	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—PSMD6—type 2 diabetes mellitus	1.06e-05	0.000629	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—SREBF1—type 2 diabetes mellitus	1.06e-05	0.000629	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—ENPP1—type 2 diabetes mellitus	1.05e-05	0.000622	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—G6PC—type 2 diabetes mellitus	1.05e-05	0.000622	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—ND1—type 2 diabetes mellitus	1.05e-05	0.000622	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—HBA2—type 2 diabetes mellitus	1.05e-05	0.000622	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—PPP1R3C—type 2 diabetes mellitus	1.05e-05	0.000622	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—CTGF—type 2 diabetes mellitus	1.04e-05	0.000617	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—HMGCR—type 2 diabetes mellitus	1.03e-05	0.000612	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—GCGR—type 2 diabetes mellitus	1.02e-05	0.000603	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—ADRA2A—type 2 diabetes mellitus	1.01e-05	0.000599	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—CYP2E1—type 2 diabetes mellitus	9.69e-06	0.000575	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—OXCT1—type 2 diabetes mellitus	9.59e-06	0.000569	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—CYTB—type 2 diabetes mellitus	9.59e-06	0.000569	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—SLC2A1—type 2 diabetes mellitus	9.58e-06	0.000569	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—CYP1A2—type 2 diabetes mellitus	9.58e-06	0.000569	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—SRD5A1—type 2 diabetes mellitus	9.35e-06	0.000555	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—CYP3A4—type 2 diabetes mellitus	9.34e-06	0.000555	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—SLC2A4—type 2 diabetes mellitus	9.19e-06	0.000545	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—GCG—type 2 diabetes mellitus	9.19e-06	0.000545	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—HSD17B3—type 2 diabetes mellitus	8.92e-06	0.000529	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—STAR—type 2 diabetes mellitus	8.92e-06	0.000529	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—ACACA—type 2 diabetes mellitus	8.92e-06	0.000529	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—ABCC8—type 2 diabetes mellitus	8.55e-06	0.000507	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—CBS—type 2 diabetes mellitus	8.55e-06	0.000507	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—COX2—type 2 diabetes mellitus	8.23e-06	0.000488	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—SLC5A2—type 2 diabetes mellitus	8.23e-06	0.000488	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—NCOA6—type 2 diabetes mellitus	8.08e-06	0.00048	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—UCP3—type 2 diabetes mellitus	7.95e-06	0.000472	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—UCP2—type 2 diabetes mellitus	7.95e-06	0.000472	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—HSD11B1—type 2 diabetes mellitus	7.95e-06	0.000472	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—GNB3—type 2 diabetes mellitus	7.92e-06	0.00047	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—PPARGC1A—type 2 diabetes mellitus	7.92e-06	0.00047	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—HMOX1—type 2 diabetes mellitus	7.88e-06	0.000468	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—CAT—type 2 diabetes mellitus	7.78e-06	0.000462	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—APOB—type 2 diabetes mellitus	7.55e-06	0.000448	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—PCK1—type 2 diabetes mellitus	7.47e-06	0.000443	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—GSTM1—type 2 diabetes mellitus	7.34e-06	0.000436	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—LPL—type 2 diabetes mellitus	7.21e-06	0.000428	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—ADCY5—type 2 diabetes mellitus	7.06e-06	0.000419	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—GPX1—type 2 diabetes mellitus	7.03e-06	0.000417	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—HK1—type 2 diabetes mellitus	7e-06	0.000415	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—CD36—type 2 diabetes mellitus	6.85e-06	0.000406	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—PPP2CA—type 2 diabetes mellitus	6.76e-06	0.000401	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—HSD3B2—type 2 diabetes mellitus	6.76e-06	0.000401	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—GCKR—type 2 diabetes mellitus	6.76e-06	0.000401	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—LPA—type 2 diabetes mellitus	6.76e-06	0.000401	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—KCNJ11—type 2 diabetes mellitus	6.76e-06	0.000401	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—MTHFR—type 2 diabetes mellitus	6.49e-06	0.000385	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—ALDOB—type 2 diabetes mellitus	6.48e-06	0.000384	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—PPARA—type 2 diabetes mellitus	6.37e-06	0.000378	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—AGT—type 2 diabetes mellitus	6.17e-06	0.000366	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—CALM1—type 2 diabetes mellitus	6.06e-06	0.00036	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—APOE—type 2 diabetes mellitus	6.04e-06	0.000359	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—GLP1R—type 2 diabetes mellitus	6.02e-06	0.000357	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—APOA1—type 2 diabetes mellitus	5.97e-06	0.000354	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—SLC2A2—type 2 diabetes mellitus	5.62e-06	0.000334	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—CPT1A—type 2 diabetes mellitus	5.51e-06	0.000327	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—MTR—type 2 diabetes mellitus	5.51e-06	0.000327	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—NAMPT—type 2 diabetes mellitus	5.4e-06	0.000321	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—HBA1—type 2 diabetes mellitus	5.37e-06	0.000319	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—LIPC—type 2 diabetes mellitus	5.37e-06	0.000319	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—GCK—type 2 diabetes mellitus	5.37e-06	0.000319	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—CYP11A1—type 2 diabetes mellitus	5.33e-06	0.000317	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—PPARG—type 2 diabetes mellitus	5.26e-06	0.000312	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—SLC9A1—type 2 diabetes mellitus	5.24e-06	0.000311	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—CETP—type 2 diabetes mellitus	5.18e-06	0.000307	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—INS—type 2 diabetes mellitus	5.16e-06	0.000306	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—PSMD6—type 2 diabetes mellitus	4.81e-06	0.000286	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—SREBF1—type 2 diabetes mellitus	4.81e-06	0.000286	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—SNAP25—type 2 diabetes mellitus	4.81e-06	0.000286	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—ALB—type 2 diabetes mellitus	4.73e-06	0.000281	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—CTGF—type 2 diabetes mellitus	4.73e-06	0.00028	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—HMGCR—type 2 diabetes mellitus	4.68e-06	0.000278	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—ADRA2A—type 2 diabetes mellitus	4.58e-06	0.000272	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—NOS3—type 2 diabetes mellitus	4.53e-06	0.000269	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—PIK3R1—type 2 diabetes mellitus	4.53e-06	0.000269	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—CYP2E1—type 2 diabetes mellitus	4.4e-06	0.000261	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—SLC2A1—type 2 diabetes mellitus	4.35e-06	0.000258	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—CYP1A2—type 2 diabetes mellitus	4.35e-06	0.000258	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—SLC2A4—type 2 diabetes mellitus	4.17e-06	0.000248	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—GCG—type 2 diabetes mellitus	4.17e-06	0.000248	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—PTGS2—type 2 diabetes mellitus	4.14e-06	0.000246	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—GNB3—type 2 diabetes mellitus	3.6e-06	0.000214	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—PPARGC1A—type 2 diabetes mellitus	3.6e-06	0.000214	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—HMOX1—type 2 diabetes mellitus	3.58e-06	0.000213	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—CAT—type 2 diabetes mellitus	3.53e-06	0.00021	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—APOB—type 2 diabetes mellitus	3.43e-06	0.000204	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—GSTM1—type 2 diabetes mellitus	3.34e-06	0.000198	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—LPL—type 2 diabetes mellitus	3.28e-06	0.000194	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—ADCY5—type 2 diabetes mellitus	3.21e-06	0.00019	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—GPX1—type 2 diabetes mellitus	3.2e-06	0.00019	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—CD36—type 2 diabetes mellitus	3.11e-06	0.000185	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—PPP2CA—type 2 diabetes mellitus	3.07e-06	0.000182	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—MTHFR—type 2 diabetes mellitus	2.95e-06	0.000175	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—PPARA—type 2 diabetes mellitus	2.89e-06	0.000172	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—AGT—type 2 diabetes mellitus	2.8e-06	0.000166	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—CALM1—type 2 diabetes mellitus	2.76e-06	0.000164	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—APOE—type 2 diabetes mellitus	2.75e-06	0.000163	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—APOA1—type 2 diabetes mellitus	2.71e-06	0.000161	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—PPARG—type 2 diabetes mellitus	2.39e-06	0.000142	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—INS—type 2 diabetes mellitus	2.35e-06	0.000139	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—ALB—type 2 diabetes mellitus	2.15e-06	0.000128	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—AKT1—type 2 diabetes mellitus	2.08e-06	0.000123	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—NOS3—type 2 diabetes mellitus	2.06e-06	0.000122	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—PIK3R1—type 2 diabetes mellitus	2.06e-06	0.000122	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—PTGS2—type 2 diabetes mellitus	1.88e-06	0.000112	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—AKT1—type 2 diabetes mellitus	9.46e-07	5.61e-05	CbGpPWpGaD
